Jean-Francois Leduc

Measuring & Accelerating Enterprise Value

📍 Canada🔄 Updated September 2026💼 7 investments📅 14 years investing🗓 Last invested Dec 2025
VC🌍 CanadaInvested this year
7
Total investments
3
Early stage
3
Mid stage
1
Late stage
14y
Years active

Portfolio

7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
LP Investor
Dec 2025
Amiral Ventures is a new founder-led, founder-backed early-stage venture capital firm, created by three seasoned veterans of the venture capital and technology industries. We lead funding rounds with both capital and hands-on expertise, dedicated to empowering exceptional entrepreneurs to build Canada’s next generation of flagship technology companies. Our inaugural fund, Amiral Fund I L.P., is focused on fueling globally competitive companies developing technologies that drive enterprise productivity, resilience, and sustainabiltiy — the pillars of tomorrow’s economy.
Investor
Sep 2022
Teams are connecting Claude and ChatGPT to their CRM and getting confidently wrong answers. In our benchmark, raw CRM + MCPs hit less than 50% accuracy on standard RevOps/GTM questions. With Vascos context graph underneath, accuracy rose to 98%. Vasco is the revenue data layer that makes AI agents trustworthy on your revenue data: shared definitions, identity resolution, plan targets, and outcome memory that MCP alone cannot provide.
Investor
May 2015
Immune Biosolutions is a clinical stage biotech company specializing in discovering and engineering avian and human antibodies for therapeutic and diagnostic applications. Our cutting-edge techniques, including phage display and single B cell screening technologies, enable us to engineer custom-fit immunotherapeutic agents. Our discovery platform is available for biotech and pharma partners, providing access to highly conserved mammalian lineage targets and opening up new possibilities for innovative therapeutics. Our biomanufacturing capacity, which has already supported successful internal clinical trials, is also available for partners in a fee-for-service model. Our internal pipeline includes several discovery programs for various cancer and infectious disease indications. Through our platform, we generate diverse antibodies with high binding affinity and novel paratopes, paving the way for exciting new approaches to treating difficult proteins.
Investor & Board Member (exited to Lightspeed HQ)
Apr 2014
Chronogolf is the fastest growing SaaS company in the Golf Industry. We provide cutting-edge management, POS, marketing, and CRM solutions to 500+ golf courses worldwide (pro.chronogolf.com). Golfers use our marketplace at www.chronogolf.com to find & book rounds of golf online. Specialties: Tee-sheet, Online booking, Promotions, Tournaments, CRM, Statistics & data analytics, Point of Sales, Webstore. Subscribe to our blog at http://blog.chronogolf.com.
Investor
Mar 2014
Hexoskin offers a SaaS platform for digital biomarker development & AI-based diagnostics, based on a unique biometric shirt. The Hexoskins Connected Health Platform is an end-to-end system that offers advanced health data analytics, clinical protocol management, and body-worn sensors. Our open platform enables 3rd party support & interoperability. Hexoskins 100% washable smart clothing capture body metrics including heart rate, breathing rate, and activity. The Hexoskin sensors offer an easy and more natural way of regularly capturing precise data in daily activities. Hexoskin apps are available for iOS & Android devices, and smartwatches. Hexoskin is also the only clinically validated system that allows ECG cardiac monitoring with lung function and activity monitoring. Hexoskin is also a cost-effective and non-invasive solution for long-term monitoring of patients and subject for healthcare, clinical research & development, sports & fitness, aerospace, space, defense & first responders. The system is designed to reduce the frequency of travel and allow remote communication between patients, study volunteers, caregivers, and researchers
Investor (exited to FYIdoctors)
Jun 2013
Founded in 2011, Montreal-based BonLook is a company that’s reimagining the way we wear glasses, taking them from seeing to being seen. BonLook is the destination for those looking to switch up their eyewear options and expand their personal glasses “wardrobe”. By making high-quality, fashionable eyewear accessible, we are revolutionizing the omnichannel shopping experience for optical solutions. Thanks to BonLook’s affordable options, prescription glasses and sunglasses are now an accessory that can be changed up season after season.
early stageRetail
Investor
Apr 2012
Founded in 2008, Anges Québec is the largest group of angel investors in Canada whose mission is to invest capital and expertise in innovative Québec-based companies. To date, the members of Anges Québec have invested more than $80M in the Québec economy, totalling more than 210 investments in over 115 innovative companies. The Anges Québec professional development centre supports its members in the constant acquisition of new investment-related knowledge and skills.
Experience · 9 entries
All (9)
Investments (7)
Board (1)
2025
LP Investor
Dec 2025
Amiral Ventures is a new founder-led, founder-backed early-stage venture capital firm, created by three seasoned veterans of the venture capital and technology industries. We lead funding rounds with both capital and hands-on expertise, dedicated to empowering exceptional entrepreneurs to build Canada’s next generation of flagship technology companies. Our inaugural fund, Amiral Fund I L.P., is focused on fueling globally competitive companies developing technologies that drive enterprise productivity, resilience, and sustainabiltiy — the pillars of tomorrow’s economy.
2022
Investor
Sep 2022
Teams are connecting Claude and ChatGPT to their CRM and getting confidently wrong answers. In our benchmark, raw CRM + MCPs hit less than 50% accuracy on standard RevOps/GTM questions. With Vascos context graph underneath, accuracy rose to 98%. Vasco is the revenue data layer that makes AI agents trustworthy on your revenue data: shared definitions, identity resolution, plan targets, and outcome memory that MCP alone cannot provide.
2015
Investor
May 2015
Immune Biosolutions is a clinical stage biotech company specializing in discovering and engineering avian and human antibodies for therapeutic and diagnostic applications. Our cutting-edge techniques, including phage display and single B cell screening technologies, enable us to engineer custom-fit immunotherapeutic agents. Our discovery platform is available for biotech and pharma partners, providing access to highly conserved mammalian lineage targets and opening up new possibilities for innovative therapeutics. Our biomanufacturing capacity, which has already supported successful internal clinical trials, is also available for partners in a fee-for-service model. Our internal pipeline includes several discovery programs for various cancer and infectious disease indications. Through our platform, we generate diverse antibodies with high binding affinity and novel paratopes, paving the way for exciting new approaches to treating difficult proteins.
Partner
Jan 2015
At Point of No Return, we are dedicated to helping executive teams get aligned, move faster and adapt to their market by taking action. This means moving away from the belief that companies are defined by plans, we prefer to focus on people.
2014
Investor & Board Member (exited to Lightspeed HQ)
Apr 2014
Chronogolf is the fastest growing SaaS company in the Golf Industry. We provide cutting-edge management, POS, marketing, and CRM solutions to 500+ golf courses worldwide (pro.chronogolf.com). Golfers use our marketplace at www.chronogolf.com to find & book rounds of golf online. Specialties: Tee-sheet, Online booking, Promotions, Tournaments, CRM, Statistics & data analytics, Point of Sales, Webstore. Subscribe to our blog at http://blog.chronogolf.com.
Show all 9 entries ↓
Investment activity
2012–2025 · 7 investments
201212013120142201512022120251
Recent (last 2 years)Earlier